Ovarian Adenocarcinoma
Also known as: Adenocarcinoma Ovary / Ovary Adenocarcinoma / Adenocarcinoma of the Ovaries / Adenocarcinoma of the Ovary / Ovarian epithelial cancer / Ovarian epithelial cancer NOS
Drug | Drug Name | Drug Description |
---|---|---|
DB00531 | Cyclophosphamide | A nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. |
DB04572 | Thiotepa | An alkylating agent used to prevent graft rejection in stem cell transplantation and to treat a variety of malignancies including certain types of adenocarcinoma and superficial bladder carcinomas. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00112 | Bevacizumab | 1 | Completed | 1 |
DB17323 | CRS-207 | 1 | Terminated | 1 |
DB00515 | Cisplatin | 1 | Completed | 1 |
DB00531 | Cyclophosphamide | 1 | Terminated | 1 |
DB17324 | Listeria monocytogenes | 1 | Terminated | 1 |
DB18452 | AVB-001 | 1 / 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Active Not Recruiting | 1 |
DB17436 | DNP-Modified autologous tumor vaccine | 1 / 2 | Unknown Status | 1 |
DB01073 | Fludarabine | 1 / 2 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Terminated | 1 |
DB14905 | Emactuzumab | 2 | Terminated | 1 |
DB16419 | Ieramilimab | 2 | Completed | 1 |
DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Terminated | 1 |
DB14892 | Spartalizumab | 2 | Completed | 1 |